Body's own cells injected into knee tendon shows promise
NCT ID NCT04753853
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested an injection of stromal vascular fraction, a mixture of cells from the patient's own fat tissue, for patellar tendinopathy (jumper's knee). Thirty participants received the injection under ultrasound guidance. The goal was to see if it could improve symptoms and function, measured by a questionnaire called VISA-P.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stromal vascular fraction injection
- What this could lead to
- If it works, this could offer a new treatment option for patellar tendinopathy that uses the body's own cells to help heal the tendon.
- What could go wrong
- This was a small, early study with only 30 participants and no comparison group. The results may not apply to everyone, and the procedure may not work better than existing treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATELLAR TENDINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istituto Ortopedico Rizzoli
Bologna, 40124, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind over elbow: can beliefs predict how tennis elbow patients respond to treatment?
- Tendon pain showdown: which injection works better?
- Needle vs light: which zaps shoulder pain best?
- Which exercise heals the knee tendon best? a Head-to-Head trial
- Could a zappy headband ease your Jumper's knee?
- Botox for groin pain? small study explores new treatment